Durable Responses With Anti-BCMA CAR T-cell for Multiple Myeloma ...Middle East

Medscape - News
For patients with heavily-pretreated multiple myeloma, responses seen with the novel chimeric antigen receptor T-cell construct ciltacabtagene autoleucel (cilta-cel) have also been durable. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Durable Responses With Anti-BCMA CAR T-cell for Multiple Myeloma )

Apple Storegoogle play

Also on site :